The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Leaders Outline Advocacy Victories, Threats

ACR Leaders Outline Advocacy Victories, Threats

October 22, 2018 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CHICAGO—ACR leaders described a series of looming legislative and regulatory threats to rheumatologists and their patients—including the proposed collapsing of evaluation and management (E/M) coding and potential changes to step therapy rules—and urged everyone in the field to make their voices heard to quash the proposals.

You Might Also Like
  • ACR Leaders Discuss E/M Coding Changes, Step Therapy & More
  • ACR/ARHP Advocacy Leaders Lobby U.S. Congress
  • Advocacy Team Celebrates Healthcare Fixes, Prepares to Face New Threats

They also recounted recent victories in the policy realm by the ACR—among them, changes to reimbursement for biosimilars and the easing of cuts to imaging reimbursement—which they say show that stepping into an advocacy role can bring results that matter.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The call to action came in a session here at the 2018 ACR/ARHP Annual Meeting.

The changes to the E/M codes are ostensibly meant to simplify documentation, by blending E/M levels 2 through 5 into a single payment, requiring documentation only at level 2, which is less onerous. But the ACR and other medical organizations say it will lower reimbursement for more complex cases.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“What it ends up meaning—and may be an unintended consequence—is reducing access to care for our patients to see us, because it reduces reimbursement pretty severely for rheumatologists,” said Angus Worthing, MD, chair of the ACR’s Government Affairs Committee. “Medicare anticipates a 3% reduction in reimbursement, which translates into a 10% pay cut.” That calculation assumes 70% overhead and 30% take-home, he said.

The ACR has led the national response to this proposal in partnership with other specialty societies, such as the American Academy of Neurology, including facilitating meetings on Capitol Hill and, with the agency, writing and coordinating a stakeholder letter from more than 130 physician and patient organizations to the CMS, and letters from members of the U.S. House of Representatives and the U.S. Senate expressing concerns.

Another threat, he said, is the proposal to allow step therapy policies—requiring physicians first try therapies they believed are doomed to fail—in Medicare Advantage Part B.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Among many legislative achievements over the past year, he said, three were spearheaded by the ACR. One was to get the federal government to restart premium processing for physicians needing an H1-B visa, which applies mostly to foreign-trained physicians practicing or finishing their training and wanting to practice in the U.S.

Also, proposed musculoskeletal ultrasound reimbursement cuts were significantly eased after the ACR argued that it is useful and safe—and often more effective than more expensive imaging.

Another success, he said, was the start of unique coding for biosimilars, which he said makes prescribing the drugs a “more provider-friendly environment.” Under the new coding, biosimilar reimbursements will no longer be pooled—lumping less and more expensive drugs together—but will be individualized.

Pages: 1 2 3 4 | Single Page

Filed Under: American College of Rheumatology, Legislation & Advocacy, Meeting Reports Tagged With: 2018 ACR/ARHP Annual Meeting, evaluation and management (E/M) coding, legislative and regulatory threats, step therapy

You Might Also Like:
  • ACR Leaders Discuss E/M Coding Changes, Step Therapy & More
  • ACR/ARHP Advocacy Leaders Lobby U.S. Congress
  • Advocacy Team Celebrates Healthcare Fixes, Prepares to Face New Threats
  • ACR Leads Coalition Response to HHS Proposed Drug Pricing Threats

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)